Staging and response assessment of lymphoma: a brief review of the Lugano classification and the role of FDG-PET/CT

The accurate assessment of initial disease status and therapeutic responses is critical to the optimal management of patients with lymphoma. Currently, staging and treatment response evaluation for lymphoma has been standardized into the Lugano classification. Lugano classification incorporates positron emission tomography (PET) into the existing response criteria, and response assessment using FDG-PET/CT has been proven to predict the prognosis in various lymphoma subtypes effectively. We will briefly review the current staging and response evaluation system and explore the role of functional imaging in the field of lymphoma.

Automated summary

Accurate assessment of disease status and treatment response is crucial for the management of lymphoma patients. The Lugano classification, incorporating the use of FDG-PET/CT, has standardized the staging and treatment response evaluation for lymphoma, effectively predicting prognosis in various subtypes.